loader
Please Wait
Applying Filters...

Annual Sales of Mavacamten reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Camzyos

PharmaCompass

01

Brand Name : Camzyos

Mavacamten

arrow
Discovery on Target
Not Confirmed

Brand Name : Camzyos

arrow
Discovery on Target
Not Confirmed

Mavacamten

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2022 Revenue in Millions : 24

2021 Revenue in Millions : 0

Growth (%) : New Launch in 2022

blank

02

Brand Name : Camzyos

Mavacamten

arrow
Luxepack
Not Confirmed

Brand Name : Camzyos

arrow
Luxepack
Not Confirmed

Mavacamten

Main Therapeutic Indication : Cardiology/Vascular Diseases

Currency : USD

2023 Revenue in Millions : 231

2022 Revenue in Millions : 24

Growth (%) : 863

blank